Harnessing CD3 diversity to optimize CAR T cells

被引:30
作者
Cardenas, Rubi M. -H. Velasco [1 ,2 ]
Brandl, Simon M. [1 ,2 ,3 ]
Melendez, Ana Valeria [1 ,2 ,3 ]
Schlaak, Alexandra Emilia [2 ,4 ]
Buschky, Annabelle [1 ,2 ,3 ]
Peters, Timo [5 ]
Beier, Fabian [6 ]
Serrels, Bryan [7 ,8 ]
Taromi, Sanaz [9 ,10 ]
Raute, Katrin [1 ,2 ,3 ]
Hauri, Simon [11 ]
Gstaiger, Matthias [11 ]
Lassmann, Silke [6 ]
Huppa, Johannes B. [5 ]
Boerries, Melanie [12 ,13 ,14 ]
Andrieux, Geoffroy [12 ]
Bengsch, Bertram [2 ,4 ]
Schamel, Wolfgang W. [1 ,2 ,15 ]
Minguet, Susana [1 ,2 ,15 ]
机构
[1] Univ Freiburg, Fac Biol, Freiburg, Germany
[2] Univ Freiburg, Signalling Res Ctr BIOSS & CIBSS, Freiburg, Germany
[3] Univ Freiburg, Spemann Grad Sch Biol & Med, Freiburg, Germany
[4] Univ Freiburg, Fac Med, Med Ctr, Clin Internal Med 2, Freiburg, Germany
[5] Med Univ Vienna, Inst Hyg & Appl Immunol, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria
[6] Inst Surg Pathol, Med Ctr, Freiburg, Germany
[7] Univ Glasgow, Wolfson Wohl Canc Res Ctr, Inst Canc Sci, Coll Med Vet & Life Sci, Glasgow, Scotland
[8] NanoString Technol Inc, Seattle, WA USA
[9] Univ Freiburg, Fac Med, Med Ctr, Dept Med 1, Freiburg, Germany
[10] Univ Furtwangen, Fac Med & Life Sci, Freiburg, Germany
[11] Swiss Fed Inst Technol, Inst Mol Syst Biol, Dept Biol, Zurich, Switzerland
[12] Univ Freiburg, Inst Med Bioinformat & Syst Med, Fac Med, Med Ctr, Freiburg, Germany
[13] German Canc Consortium, Freiburg, Germany
[14] German Canc Res Ctr, Freiburg, Germany
[15] Univ Clin & Med Fac, Ctr Chron Immunodeficiency, Freiburg, Germany
关键词
MEMORY STEM-CELLS; B-CELL; EXPRESSION; THERAPY; TCR; LYMPHOCYTES; ACTIVATION; GENERATION; COMPLEX; BINDING;
D O I
10.1038/s41590-023-01658-z
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Current US Food and Drug Administration-approved chimeric antigen receptor (CAR) T cells harbor the T cell receptor (TCR)-derived zeta chain as an intracellular activation domain in addition to costimulatory domains. The functionality in a CAR format of the other chains of the TCR complex, namely CD3 delta, CD3 epsilon and CD3 gamma, instead of zeta, remains unknown. In the present study, we have systematically engineered new CD3 CARs, each containing only one of the CD3 intracellular domains. We found that CARs containing CD3 delta, CD3 epsilon or CD3 gamma cytoplasmic tails outperformed the conventional zeta CAR T cells in vivo. Transcriptomic and proteomic analysis revealed differences in activation potential, metabolism and stimulation-induced T cell dysfunctionality that mechanistically explain the enhanced anti-tumor performance. Furthermore, dimerization of the CARs improved their overall functionality. Using these CARs as minimalistic and synthetic surrogate TCRs, we have identified the phosphatase SHP-1 as a new interaction partner of CD3 delta that binds the CD3 delta-ITAM on phosphorylation of its C-terminal tyrosine. SHP-1 attenuates and restrains activation signals and might thus prevent exhaustion and dysfunction. These new insights into T cell activation could promote the rational redesign of synthetic antigen receptors to improve cancer immunotherapy. Minguet and colleagues systematically examine how individual CD3 chains of the TCR-CD3 complex can improve chimeric antigen receptor (CAR) T cell performance.
引用
收藏
页码:2135 / 2149
页数:34
相关论文
共 57 条
[11]   Expression of fully assembled TCR-CD3 complex on double positive thymocytes: synergistic role for the PRS and ER retention motifs in the intra-cytoplasmic tail of CD3ε [J].
Brodeur, Jean-Francois ;
Li, Samantha ;
Damlaj, Ousama ;
Dave, Vibhuti P. .
INTERNATIONAL IMMUNOLOGY, 2009, 21 (12) :1317-1327
[12]   Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia [J].
Davila, Marco L. ;
Riviere, Isabelle ;
Wang, Xiuyan ;
Bartido, Shirley ;
Park, Jae ;
Curran, Kevin ;
Chung, Stephen S. ;
Stefanski, Jolanta ;
Borquez-Ojeda, Oriana ;
Olszewska, Malgorzata ;
Qu, Jinrong ;
Wasielewska, Teresa ;
He, Qing ;
Fink, Mitsu ;
Shinglot, Himaly ;
Youssif, Maher ;
Satter, Mark ;
Wang, Yongzeng ;
Hosey, James ;
Quintanilla, Hilda ;
Halton, Elizabeth ;
Bernal, Yvette ;
Bouhassira, Diana C. G. ;
Arcila, Maria E. ;
Gonen, Mithat ;
Roboz, Gail J. ;
Maslak, Peter ;
Douer, Dan ;
Frattini, Mark G. ;
Giralt, Sergio ;
Sadelain, Michel ;
Brentjens, Renier .
SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (224)
[13]   An orderly inactivation of intracellular retention signals control surface expression of the T cell antigen receptor [J].
Delgado, P ;
Alarcón, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (04) :555-566
[14]   CD3-GAMMA CONTAINS A PHOSPHOSERINE-DEPENDENT DI-LEUCINE MOTIF INVOLVED IN DOWN-REGULATION OF THE T-CELL RECEPTOR [J].
DIETRICH, J ;
HOU, XH ;
WEGENER, AMK ;
GEISLER, C .
EMBO JOURNAL, 1994, 13 (09) :2156-2166
[15]   Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients [J].
Dudley, ME ;
Wunderlich, JR ;
Shelton, TE ;
Even, J ;
Rosenberg, SA .
JOURNAL OF IMMUNOTHERAPY, 2003, 26 (04) :332-342
[16]   SPECIFIC ACTIVATION AND TARGETING OF CYTOTOXIC LYMPHOCYTES THROUGH CHIMERIC SINGLE CHAINS CONSISTING OF ANTIBODY-BINDING DOMAINS AND THE GAMMA-SUBUNIT OR ZETA-SUBUNIT OF THE IMMUNOGLOBULIN AND T-CELL RECEPTORS [J].
ESHHAR, Z ;
WAKS, T ;
GROSS, G ;
SCHINDLER, DG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) :720-724
[17]   Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency [J].
Feucht, Judith ;
Sun, Jie ;
Eyquem, Justin ;
Ho, Yu-Jui ;
Zhao, Zeguo ;
Leibold, Josef ;
Dobrin, Anton ;
Cabriolu, Annalisa ;
Hamieh, Mohamad ;
Sadelain, Michel .
NATURE MEDICINE, 2019, 25 (01) :82-+
[18]  
Finney HM, 1998, J IMMUNOL, V161, P2791
[19]  
Gao Y., 2009, OPTICA, V57, P285
[20]  
Gattinoni L, 2005, J CLIN INVEST, V115, P1616, DOI 10.1172/JCI24480